Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Hanall Biopharma Co Ltd Appoints New Co-CEO


Friday, 22 Mar 2013 03:24am EDT 

Hanall Biopharma Co Ltd announced that it has appointed Park Seung Guk as its new Co-Chief Executive Officer, effective March 22, 2013. The current Chief Executive Officer, Kim Seong Wuk, continues his duty as Co-CEO at the Company. 

Company Quote

3940.0
-55.0 -1.38%
9:34pm EST